Home / Stocks / Aster Dm Quality Care Ltd
ASTERDM

Aster Dm Quality Care Ltd Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹739.3

Change

+8.3 (1.14%)

Open

₹734.0

Prev. Close

₹731.0

Day High

₹740.45

Day Low

₹727.0

Volume Analysis

Traded

373,933

Delivered

211,299

Delivery %

56.51%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (2)

  • •Promoter holding is rising
  • •Strong operating margin (21.0%)

Weaknesses (0)

No signal for this stock

Opportunities (1)

  • •Strong 3-year revenue growth (15.8%)

Threats (1)

  • •FII holding has been falling

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹757.61 ₹749.03 ₹744.16 ₹735.58 ₹730.71 ₹722.13 ₹717.26
Fibonacci ₹749.03 ₹743.89 ₹740.72 ₹735.58 ₹730.44 ₹727.27 ₹722.13
Camarilla ₹743.0 ₹741.77 ₹740.53 ₹735.58 ₹738.07 ₹736.83 ₹735.6

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

+21.86%

1 Week

+0.46%

1 Month

+13.71%

3 Months

-2.92%

6 Months

-2.29%

1 Year

+11.12%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹122.74

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

5.07%

Net margin 8.67% × asset turnover 0.26x × equity multiplier 2.25x

Company Overview

Sector

Healthcare

Market Cap

₹63,907 Cr

P/E (TTM)

122.0

ROE

11.3%

Book Value

₹89.4

Face Value

₹10.0

Source: Screener.in (Consolidated figures) — data as of 18 Nov 2026. Not investment advice.

TopFund Analysis

Aster Dm Quality Care Ltd lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 59/100. The strongest factor is Corporate Governance (100/100), while Valuation (1/100) is the weakest area to weigh before deciding. Notably: Promoter holding is rising; strong operating margin (21.0%). FII holding has been falling.

TopFund Score — Fundamentals Quality

59/100 — Average

Data confidence: 80/100 (High Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

73

Growth

44

Valuation

1

Cash Flow

71

Corporate Governance

100

Momentum

58

Institutional Ownership

55

Business Quality

62

Risk & Volatility

69

Liquidity

86

From Screener.in

  • +Company is expected to give good quarter
  • +Company has been maintaining a healthy dividend payout of 1,560%
  • +Promoter holding has increased by 13.4% over last quarter.
  • −Stock is trading at 8.17 times its book value
  • −Company has a low return on equity of 8.46% over last 3 years.
  • −Company might be capitalizing the interest cost
  • −Promoters have pledged 67.0% of their holding.

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Transcript of Earnings Conference Call for the quarter and half year ended 30 September 2026

Newspaper Advertisement regarding dispatch of the Notice of Postal Ballot of the Company

Newspaper publication regarding unaudited financial results for the quarter and half year ended 30 September 2026

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales + 929 955 974 1,002 1,086 1,050 1,000 1,078 1,197 1,186 1,182 1,311 2,829
Expenses + 787 805 817 841 869 864 818 876 961 983 958 1,055 2,174
Operating Profit 142 149 156 161 217 186 182 202 236 202 224 256 655
OPM % 15.0% 16.0% 16.0% 16.0% 20.0% 18.0% 18.0% 19.0% 20.0% 17.0% 19.0% 20.0% 23.0%
Other Income + -64 153 -40 5,120 35 9 5 29 28 0 37 -77 33
Interest 30 25 30 29 31 31 32 31 31 31 30 31 119
Depreciation 54 57 58 60 62 62 64 63 66 68 67 69 150
Profit before tax -7 220 28 5,191 159 102 91 136 167 103 163 78 419
Tax % 120.0% 5.0% 108.0% 1.0% 33.0% 37.0% 6.0% 31.0% 27.0% 43.0% 6.0% 62.0% 23.0%
Net Profit + -15 209 -2 5,152 106 64 86 94 121 59 154 29 322
EPS in Rs -1 4 0 103 2 1 2 2 2 1 3 0 3
Raw PDF — — — — — — — — — — — — —
YoY Sales growth -67 -70 21 19 17 10 3 8 10 13 18 22 136

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 3,876 5,250 5,931 6,721 7,963 8,652 8,608 10,253 2,994 3,699 4,138 4,643 6,508
Expenses + 3,370 4,805 5,582 6,089 6,886 7,187 7,506 8,720 2,547 3,124 3,383 3,769 5,170
Operating Profit 506 445 349 632 1,077 1,465 1,103 1,533 447 575 756 875 1,338
OPM % 13.0% 8.0% 6.0% 9.0% 14.0% 17.0% 13.0% 15.0% 15.0% 16.0% 18.0% 19.0% 21.0%
Other Income + 23 25 453 177 -155 -158 53 51 353 32 5,168 91 -9
Interest 79 189 371 204 205 391 334 307 96 119 133 132 212
Depreciation 144 243 322 298 306 586 618 641 192 220 249 264 354
Profit before tax 306 38 108 308 410 330 205 637 511 268 5,542 570 764
Tax % 11.0% 78.0% 10.0% 8.0% 10.0% 5.0% 13.0% 6.0% 7.0% 21.0% 2.0% 25.0% —
Net Profit + 272 8 98 282 367 315 178 601 475 212 5,408 427 564
EPS in Rs 6 0 2 5 7 6 3 11 9 3 108 7 7
Dividend Payout % 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 4,637.0% 5.0% 40.0% —
Sales growth 35 35 13 13 18 9 0 19 -71 24 12 12 50

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Reserves 1,096 17 1,472 2,327 2,709 2,775 2,875 3,080 3,574 3,686 2,554 3,683 6,919
Borrowings + 1,091 3,321 2,758 2,352 2,788 5,605 4,804 5,282 6,075 1,758 2,392 2,594 5,940
Other Liabilities + 1,834 2,003 2,171 2,296 2,926 3,528 3,444 3,661 4,687 12,039 1,154 1,280 3,792
Total Liabilities 4,409 5,743 6,804 7,479 8,928 12,405 11,620 12,521 14,836 17,983 6,600 8,076 17,523
Fixed Assets + 2,237 2,507 3,520 3,738 4,289 7,124 6,749 7,009 9,052 3,175 3,920 4,242 12,205
CWIP 197 358 290 402 550 736 934 998 279 170 293 420 529
Investments 3 39 32 38 22 34 63 45 80 17 245 1,167 422
Other Assets + 1,972 2,839 2,962 3,302 4,067 4,511 3,874 4,470 5,425 14,620 2,142 2,248 4,366
Total Assets 4,409 5,743 6,804 7,479 8,928 12,405 11,620 12,521 14,836 17,983 6,600 8,076 17,523
Equity Capital 389 403 403 505 505 497 497 500 500 500 500 518 872

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 236 203 361 537 601 1,223 1,569 1,314 1,834 158 425 656
Cash from Investing Activity + -439 -775 -1,136 -522 -702 -658 -333 -563 -951 -878 6,015 -288
Cash from Financing Activity + 203 578 654 46 134 -675 -1,116 -686 -817 1,053 -6,358 -304
Net Cash Flow -1 5 -122 61 33 -110 120 65 66 332 82 63
Free Cash Flow -176 -536 -565 23 64 715 1,183 770 995 -601 70 179
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 51 53 116 93 61 88 143 89 424 40 71 93

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 41.88% → 53.78%
  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Others 0.37% 0.35% 0.32% 0.3% 0.28% 0.26% 0.25% 0.23% 0.23% 0.23% 0.0% 0.11%
Public 9.61% 10.59% 14.38% 13.05% 12.3% 11.6% 14.45% 14.33% 14.8% 14.61% 21.41% 12.17%
Promoters 41.88% 41.88% 41.88% 41.88% 41.88% 41.89% 40.39% 40.39% 40.39% 40.39% 40.39% 53.78%
FII 41.0% 33.48% 27.08% 23.86% 22.62% 21.66% 19.64% 18.72% 18.46% 17.18% 10.53% 12.26%
DII 7.15% 13.7% 16.35% 20.91% 22.91% 24.58% 25.28% 26.32% 26.12% 27.57% 27.65% 21.66%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Aster Dm Quality Care Ltd (this stock) 63,907 122.0 8.2 11.3%
Alkem Laboratories Ltd. 61,875 28.6 4.16 18.9%
Fortis Healthcare Ltd 61,047 56.9 5.81 11.2%
Biocon Limited. 58,962 86.5 1.69 1.4%
Glenmark Pharmaceuticals 73,937 36.5 6.59 23.6%
Gland Pharma Limited 53,710 42.9 5.01 10.7%
Anthem Biosciences Ltd 51,355 81.4 15.65 22.3%

Which Mutual Funds Hold Aster Dm Quality Care Ltd?

Frequently Asked Questions about Aster Dm Quality Care Ltd

Community Sentiment

What are other investors saying about Aster Dm Quality Care Ltd?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.